US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 11.910
  • +0.140+1.19%
Close Nov 27 16:00 ET
  • 11.910
  • 0.0000.00%
Post 16:02 ET
630.84MMarket Cap-5725P/E (TTM)

Stoke Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.267M--
--2024/Q4-- / 4.100M--
--2024/Q34.894M / 3.600M--
--2024/Q24.831M / 3.256M--
--2024/Q14.216M / 3.214M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.267M--
--2024/Q4-- / 4.100M--
--2024/Q34.894M / 3.600M--
--2024/Q24.831M / 3.256M--
--2024/Q14.216M / 3.214M--

Unlock Free Earnings Estimates

Stoke Therapeutics Earnings Reports

  • Stoke Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 16:06 ET

  • Stoke Therapeutics | 8-K: Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

    Nov 5 07:06 ET

  • Stoke Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:10 ET

  • Stoke Therapeutics | 8-K: Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates

    Aug 7 07:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data